Biotronik has announced results from the BIOSOLVE-II trial, investigating the safety and clinical performance of the world’s first clinically proven magnesium-based bioresorbable scaffold, at the Transcatheter Cardiovascular Therapeutics (TCT) 2015. The bioresorbable scaffold met its primary angiographic endpoint and demonstrated an outstanding safety profile. The announcement of clinical data from BIOSOLVE-II will be accompanied by publication in The Lancet.

C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-World Registry at the Transcatheter Cardiovascular Therapeutics (TCT) 2015 meeting. These results come just months after publication in the New England Journal of Medicine of the one-year data from the Lutonix 035 drug coated balloon (DCB) catheter pivotal, randomized LEVANT 2 trial.

Tryton Medical Inc. announced results from the pivotal Tryton Confirmatory Study confirming the acceptable acute safety profile of the Tryton Side Branch Stent for the treatment of coronary bifurcation lesions in vessels appropriate for a ≥2.5mm stent. Results were presented as part of the Featured Clinical Research session at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF) being held in San Francisco, California.

On Oct. 7, 2015, Cook Medical initiated a voluntary recall for select sizes of Beacon Tip Angiographic Catheters. This recall includes all lots of these select sizes of the Beacon Tip Angiographic Catheters. This recall is an expansion of the voluntary lot-specific recall issued on July 2, 2015.

AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has agreed to acquire nContact Inc., a privately held developer of innovative cardiac ablation solutions.

Boston Scientific Corp. announced it has closed on an additional round of financing with MValve Technologies Ltd., developer of a percutaneous mitral valve replacement system designed to work with the Boston Scientific Lotus Valve. Boston Scientific has provided the company with funding since 2012 and has an exclusive option to acquire MValve.

Kopp Development Inc. has released a new entryway system for magnetic resonance imaging (MRI) rooms — FerrAlert Halo II Plus. This detection system dramatically reduces alarm fatigue by not alarming on the MRI door and ferromagnetic objects exiting the MRI room. Alarm fatigue reduction is a top priority for ECRI and The Joint Commission.

The Lancet published results online that show Abbott’s ARCHITECT STAT High Sensitive Troponin-I (hsTnl) test may rule out myocardial infarction (MI) in two-thirds of very-low risk patients, allowing prompt discharge from A&E (Accident and Emergency). The study identified a precise new threshold of troponin of <5 ng/L which, together with other clinical factors, allows doctors to rule out heart attacks in the majority of patients, reducing prolonged waiting for monitoring with additional tests, unnecessary procedures and hospital admissions.

October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest innovations from Cordisduring the 27th Transcatheter Cardiovascular Therapeutics (TCT) conference Oct. 11-15, 2015 in San Francisco. Attendees will gain insight to the Cardinal Health and Cordis comprehensive offering of daily-use products; reliable, trackable inventory and logistics, and deep analytic capabilities. This multi-dimensional set of solutions will become increasingly important with emerging value-based payment models.

Oregon Health & Science University (OHSU) now offers patients one of the most advanced computed tomography (CT) imaging systems available with the installation of Toshiba’s Aquilion ONE ViSION Edition. OHSU, a nationally prominent research university and Oregon’s only public academic medical center, acquired the new system to help improve its diagnostic capabilities for trauma, cardiac, stroke and pediatric patients. Adding the first 640-slice system in the state of Oregon allows OHSU to deliver better patient care and maintain its position as one of the leading health care institutions in the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now